Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial final discussion on the current scenario of cancer. The field of oncology is in the midst of a transformative era, driven by the profound importance of genomic testing and remarkable advancements in both diagnosis and treatment. In the past, cancer was often categorized by its anatomical location, leading to a "one-size-fits-all" approach. However, with the integration of cutting-edge technologies, we can now precisely identify the unique molecular and genetic drivers of each patient's tumor. This shift toward personalized medicine has enabled the development of highly effective targeted therapies and immunotherapies, which offer superior outcomes and fewer side effects compared to traditional cytotoxic chemotherapy.
The central pillar of this revolution is genomic testing, which provides a detailed blueprint of a tumor's genetic makeup. By identifying specific mutations, fusions, or other genomic alterations, clinicians can select treatments that directly target these abnormalities. This not only enhances therapeutic efficacy but also helps predict treatment resistance and informs clinical trial eligibility. Furthermore, advancements in diagnostic techniques, such as liquid biopsies and next-generation sequencing, are making it possible to detect cancer at earlier stages and monitor treatment response with unprecedented accuracy. This empowers healthcare providers to make more informed decisions, ensuring each patient receives the most appropriate and advanced care available.
Therefore, join Dr. Poonam Patil for this final discussion to gain a comprehensive understanding of how genomic testing is reshaping the current scenario of cancer care. Listen to the expert insights, grasp the shared knowledge on advancements in diagnosis and treatment, and continue to follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
2.
Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers
3.
In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.
4.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
5.
WHO launches plan for free child cancer medicines
1.
Innovative Directions in Hematology Across Clinical Settings
2.
Transformative Approaches in Hematology for Healthcare Excellence
3.
How HLH is Revolutionizing Healthcare
4.
Essential Perspectives in Hematology and Patient Outcomes
5.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Navigating the Complexities of Ph Negative ALL - Part III
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
Navigating the Complexities of Ph Negative ALL - Part X
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation